Central America vs Uganda: Proportion of the target population who received the final dose of
Central America
79.0%
in 2024
Uganda
95.0%
in 2024
Central America rank
1st
Uganda rank
4th
Proportion of the target population who received the final dose of over time
- Central America
- Uganda
How they compare
Uganda currently reports 95.0% against 79.0% in Central America, a difference of 16.0%.
That makes Uganda's figure about 1.2 times Central America's.
The two have swapped places 3 times across 9 shared years of data; in 2016 it was Central America ahead.
Central America ranks 1st and Uganda ranks 4th of 35 groups.
Across the 2 decades both report, Central America averaged higher in 1 and Uganda in 1.
Head to head by decade
| Decade | Central America | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.2% | 57.2% | 16.0% | Central America |
| 2020s | 47.6% | 61.0% | 13.4% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central America or Uganda?
- Uganda, at 95.0% against 79.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central America and Uganda?
- 16.0%, with Uganda ahead.
- How many years of comparable data are there for Central America and Uganda?
- 9 years are reported by both, from 2016 to 2024.
- How do Central America and Uganda rank globally for proportion of the target population who received the final dose of?
- Central America ranks 1st and Uganda ranks 4th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.